Malignant melanoma in a psoriasis patient after sequential treatment with biologics.

Peter, Jelissa Katharina; Müller, Simon; Navarini, Alexander; Maul, Lara Valeska

Peter, Jelissa Katharina; Müller, Simon; Navarini, Alexander; Maul, Lara Valeska.

Affiliation

Peter JK; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
Müller S; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
Navarini A; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.
Maul LV; Department of Dermatology, University Hospital of Basel, Basel, Switzerland.

Dermatol Ther ; 35(6): e15435, 2022 06.

Article in En | MEDLINE | ID: mdl-35278022

Subject(s)

Biological Products; Melanoma; Psoriasis; Biological Factors; Biological Products/adverse effects; Humans; Melanoma/drug therapy; Psoriasis/diagnosis; Psoriasis/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Biological Products / Melanoma Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Dermatol Ther Journal subject: DERMATOLOGIA Year: 2022 Type: Article Affiliation country: Switzerland

Fulltext

XML

PubMed Links

Search on Google